Pluristem Awarded Stem Cell Therapy Patent – Drug Discovery & Development
|
Pluristem Awarded Stem Cell Therapy Patent
Drug Discovery & Development Pluristem is studying a placenta-based stem cell therapy called PLX as a treatment for conditions including peripheral artery disease, or the narrowing of large arteries that supply blood to the extremities. In June, the Food and Drug Administration … Pluristem Therapeutics Inc. (PSTI): Celgene’s And Osiris’ IP Positions …Seeking Alpha |
